Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors—is it time for a paradigm shift?

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Katerina Chatzidionysiou, Matina Liapi, Georgios Tsakonas, Iva Gunnarsson, Anca Catrina

Journal title: Clinical Rheumatology

Journal publisher: Springer Verlag

Published year: 2020

DOI identifier: 10.1007/s10067-020-05420-w

ISSN: 0770-3198